AzTrials
AzTrials

Prevalence of Psychoactive Substances in Road TrafficNCT00570518

Alcohol and Other Psychoactive Substances in Road Traffic - a Case-control Study

An observational study of Prevalence of Psychoactive Substances in Road Traffic and Psychoactive Substances in Accident Involved Drivers, run by Finnish Institute for Health and Welfare at 1 site in Finland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The main purpose of the study is to determine the accident risk when driving under the influence of psychoactive substances, including alcohol (DUI). Other aims are to find out the prevalence of psychoactive substances in road traffic and to obtain information on the role of these substances in road traffic accident… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
How many people
4,500 participants
Where
1 siteFinland
Study dates
Sep 2007to Oct 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: drivers of motorised vehicles and bicycles in general road traffic or drivers of motorised vehicles and bicycles, injured or killed in road traffic accidents

Who may be able to join

  • 18 years or older
  • driver of a motorised vehicle or bicycle
  • is willing to participate to the study (not applicable to the diseased drivers; information obtained from a register database)

Who cannot join

  • 17 or younger
  • not the driver of a motorised vehicle or bicycle
  • does not want to participate (not applicable to the diseased drivers; information obtained from a register database)

Trial locations and contacts

1 site in 1 country.

Pirjo Lillsunde, Dr contact

+358947448342

pirjo.lillsunde@ktl.fi

Charlotta Engblom, M.Sc.(Tech.) contact

+358947448546

charlotta.engblom@ktl.fi

Finland1 site, 1 recruiting
  • National Public Health Institute

    Helsinki, 00300

    Pirjo Lillsunde, Dr, +358947448342, pirjo.lillsunde@ktl.fi

    Charlotta Engblom, M.Sc.(Tech.), +358947448546, charlotta.engblom@ktl.fi

    Recruiting

Other trials in Finland

About this study

Official title: DRUID Work Package 2 - Epidemiology

The main purpose of the study is to determine the accident risk when driving under the influence of psychoactive substances, including alcohol (DUI). Other aims are to find out the prevalence of psychoactive substances in road traffic and to obtain information on the role of these substances in road traffic accident causations.

For the purposes of the study, drivers of motorised vehicles are randomly stopped and interviewed and breath alcohol is recorded. Also, an oral fluid sample is taken and psychoactive substances are investigated in the laboratory. For cases, drivers injured in traffic accidents are asked to participate to the study. A whole blood sample and, if possible, an oral fluid sample is taken and psychoactive substances are determined in the laboratory. Also, people diseased in road traffic accident are included in the study. The information required for these subjects are taken from a register database.

The study is part of an EU-project DRUID. Altogether 13 European countries take part to the study.

Keywords
driving under the influence, psychoactive substances, roadside surveys, hospital surveys, accident involvement risk estimation
Medical subject headings
Driving Under the Influence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00570518
Study groupRoleWhat they receive
1randomly stopped drivers of motorised vehicles and bicycles
2drivers of motorised vehicles and bicycles injured or killed in road traffic accidents

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. relative risk estimation of accident involvement for drivers impaired by psychoactive substances

    Measured: three years

Secondary outcomes (2)
  1. prevalence of psychoactive substances in the general driving population

    Measured: three years

  2. prevalence of psychoactive substances among accident involved drivers

    Measured: three years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Dec 2007 (estimated)
  2. Study startSep 2007
  3. Study completionOct 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Enrolment
4,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00570518
Sponsor's protocol ID
KTL 403-2
Other IDs
404-3, 405-9, 406-5
Status last verified
Sep 2011
First submitted
10 Dec 2007
Last updated
3 Oct 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Prevalence of Psychoactive Substances in Road Traffic and Psychoactive Substances in Accident Involved Drivers, run by Finnish Institute for Health and Welfare at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Oct 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Pirjo Lillsunde, Dr (+358947448342, pirjo.lillsunde@ktl.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

relative risk estimation of accident involvement for drivers impaired by psychoactive substances (time frame: three years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in